Literature DB >> 23239309

Use of Doppler echocardiography to support the decision to discontinue secondary prophylaxis for patients with rheumatic fever and normal cardiac auscultation.

Fátima Derlene da Rocha Araújo1, Eugênio Marcos de Andrade Goulart, Zilda Maria Alves Meira.   

Abstract

Secondary prophylaxis remains the safest way to prevent or minimize heart valve damage in patients with rheumatic fever. However, criteria to determine the duration of prophylaxis have not been well established. This study aimed to evaluate the clinical and Doppler echocardiographic profile of patients with rheumatic fever and a normal clinical examination at least 5 years after the first episode and to discuss the contribution of Doppler echocardiography in supporting the decision to discontinue secondary prophylaxis. An observational longitudinal study analyzing 183 patients with rheumatic fever and a normal clinical examination 5 years or more after the initial attack was conducted. The patients underwent Doppler echocardiography to study the severity of mitral or aortic valvular disease. Of the 183 patients, 77 (42 %) had clinical carditis. Subclinical chronic heart disease occurred for 79 % of the patients with previous clinical carditis and for 25 % of the patients without clinical carditis. Of the 35 patients with previous clinical carditis who were in the period of discontinued prophylaxis, residual valvular heart disease was observed in all, whereas of the 62 patients without clinical carditis, only 27 % showed residual valvular heart disease. Considering Doppler echocardiographic criteria, prophylaxis would be continued for 13 (34 %) of the patients with previous clinical carditis and for only 2 (3 %) of those without clinical carditis. Return of cardiac auscultation to normal is not always accompanied by return of Doppler echocardiographic findings to normal. Criteria regarding Doppler echocardiographic findings and valve morphology should be evaluated by the time secondary prophylaxis is discontinued. However, further studies are needed to demonstrate whether prolonged prophylaxis provides any benefit to patients with persistent echocardiographic findings.

Entities:  

Mesh:

Year:  2012        PMID: 23239309     DOI: 10.1007/s00246-012-0601-4

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  21 in total

1.  Diagnosis of active rheumatic carditis. The echoes of change.

Authors:  J Narula; Y Chandrasekhar; S Rahimtoola
Journal:  Circulation       Date:  1999-10-05       Impact factor: 29.690

Review 2.  The global burden of group A streptococcal diseases.

Authors:  Jonathan R Carapetis; Andrew C Steer; E Kim Mulholland; Martin Weber
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

3.  2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Robert O Bonow; Blase A Carabello; Kanu Chatterjee; Antonio C de Leon; David P Faxon; Michael D Freed; William H Gaasch; Bruce W Lytle; Rick A Nishimura; Patrick T O'Gara; Robert A O'Rourke; Catherine M Otto; Pravin M Shah; Jack S Shanewise
Journal:  Circulation       Date:  2008-09-26       Impact factor: 29.690

4.  Echocardiographic diagnosis of subclinical carditis in acute rheumatic fever.

Authors:  N J Wilson; J M Neutze
Journal:  Int J Cardiol       Date:  1995-06-02       Impact factor: 4.164

Review 5.  Consensus guidelines on pediatric acute rheumatic fever and rheumatic heart disease.

Authors:  Anita Saxena; R Krishna Kumar; Rani Prem Kumar Gera; S Radhakrishnan; Smita Mishra; Z Ahmed
Journal:  Indian Pediatr       Date:  2008-07       Impact factor: 1.411

6.  Rheumatic fever in the Kimberley region of Western Australia.

Authors:  P Richmond; L Harris
Journal:  J Trop Pediatr       Date:  1998-06       Impact factor: 1.165

7.  The Nicaraguan Health and Demographic Surveillance Site, HDSS-Leon: a platform for public health research.

Authors:  Rodolfo Peña; Wilton Pérez; Marlon Meléndez; Carina Källestål; Lars-Ake Persson
Journal:  Scand J Public Health       Date:  2008-05       Impact factor: 3.021

8.  Sequelae of the initial attack of acute rheumatic fever in children from north India. A prospective 5-year follow-up study.

Authors:  S K Sanyal; A M Berry; S Duggal; V Hooja; S Ghosh
Journal:  Circulation       Date:  1982-02       Impact factor: 29.690

Review 9.  Rheumatic fever diagnosis, management, and secondary prevention: a New Zealand guideline.

Authors:  Polly Atatoa-Carr; Diana Lennon; Nigel Wilson
Journal:  N Z Med J       Date:  2008-04-04

10.  An Australian guideline for rheumatic fever and rheumatic heart disease: an abridged outline.

Authors:  Jonathan R Carapetis; Alex Brown; Nigel J Wilson; Keith N Edwards
Journal:  Med J Aust       Date:  2007-06-04       Impact factor: 7.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.